Autonomic Receptors and Medication Groups

Cholinergic Receptors (Parasympathetic)

• Muscarinic: These are organ-specific receptors that, when activated, increase secretions, promote bladder contraction, and slow the heart.
• Nicotinic: Involved in ganglionic transmission and skeletal muscle activation.

Major Medication Groups

Pharmacological agents are categorized by whether they activate or block these receptors.

1. Adrenergic Agonists

These medications activate adrenergic receptors to mimic sympathetic responses.

• Epinephrine: A potent agonist that hits $\alpha$ and $\beta$ receptors. It is used in anaphylaxis to increase blood pressure ($\alpha_1$), stimulate the heart ($\beta_1$), and open airways ($\beta_2$).
• Norepinephrine: Primarily used for severe hypotension; it provides strong vasoconstriction via $\alpha$ activity.
• Albuterol: A selective $\beta_2$ agonist used to relieve bronchospasm by relaxing bronchial muscle.
• Clonidine: An $\alpha_2$ agonist. Uniquely, by activating these central receptors, it decreases sympathetic signaling, thereby lowering blood pressure.

2. Adrenergic Antagonists

These medications block adrenergic receptors to prevent sympathetic responses.

• Alpha-1 Antagonists (e.g., Prazosin): Block vasoconstriction, leading to vasodilation and lower blood pressure.
• Beta Antagonists (e.g., Metoprolol, Propranolol): Block the effects of adrenaline on the heart and lungs. Metoprolol is "relatively $\beta_1$-selective," meaning it targets the heart more than the lungs.

Exam Tip: When assessing a patient on Beta-blockers, always check their heart rate and blood pressure. Be cautious with non-selective blockers (like Propranolol) in patients with asthma, as they can block $\beta_2$ receptors and cause bronchoconstriction.

3. Cholinergic Agonists and Cholinesterase Inhibitors

These increase cholinergic activity (parasympathetic).

• Bethanechol: A muscarinic agonist used for urinary retention; it stimulates the bladder to contract.
• Pyridostigmine: A cholinesterase inhibitor used in Myasthenia Gravis. It prevents the breakdown of acetylcholine, increasing its availability to improve muscle strength.

4. Antimuscarinic Medications

These block muscarinic receptors, effectively "turning off" many parasympathetic responses.

• Atropine: Used to treat symptomatic bradycardia by reducing vagal (parasympathetic) effects on the heart.
• Oxybutynin: Used for overactive bladder to reduce involuntary contractions.
• Ipratropium: Used in COPD to reduce bronchoconstriction.

Clinical Warning: Antimuscarinic drugs often cause "drying" effects. Common side effects include dry mouth, constipation, urinary retention, and blurred vision.

Clinical Application and Safety

Effective nursing care requires connecting the drug's mechanism to the patient's clinical presentation.

Case Study: The Dizziness Factor If a patient taking Prazosin (an $\alpha_1$ antagonist) reports dizziness when standing, the nurse should recognize that the medication is working by causing vasodilation. If that patient also has a history of poor fluid intake or diarrhea, the risk of orthostatic hypotension is significantly increased.

Case Study: The Confusion Factor An older adult taking Oxybutynin (an antimuscarinic) who develops new confusion, constipation, and difficulty urinating is likely experiencing an accumulation of antimuscarinic effects. In older adults, these medications can significantly impact cognitive status.

To ensure safety, always evaluate the "Five Pillars of Treatment Response":

1. Target: What is being treated?
2. Mechanism: What physiological change should happen?
3. Baseline: What was the status before the drug?
4. Risk: What indicates toxicity or harm?
5. Outcome: What finding shows the drug worked?